Biaxin
Product Images NDC 54868-3820

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Biaxin (NDC 54868-3820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 250 mg / 5 mL Package Label (3384)

Label for Biaxin 250mg/5mL oral suspension, 100 mL bottle, distributed by Physicians Total Care, Inc. in Tulsa, OK. It includes the NDC 54868-3384-0, lot number, expiration date, and barcode. Manufactured by Abbott Laboratories, North Chicago, IL.*

FDA Label Image

Image Of 500 mg Xl Package Label (4191)

Packaging label for Biaxin XL 500 mg extended-release tablets by Physicians Total Care, Inc. The label states a package count of 20 tablets and includes caution against dispensing without prescription. The active ingredient, clarithromycin, is noted along with dosing and storage instructions. A barcode and lot number with expiration date are also visible.*

FDA Label Image

Chemical Structure For Clarithromycin (Biaxin Tab Stucture)

Chemical structure diagram of the active ingredient in Biaxin, illustrating the molecular composition and connectivity of its atoms in a detailed two-dimensional format.*

FDA Label Image

Survival Graph (Biaxin Tab Survival Graph)

A survival curve chart comparing the proportion surviving over days since randomization for Clarithromycin versus Placebo. The x-axis is labeled 'Days Since Randomization' and the y-axis is labeled 'Proportion Surviving.' Clarithromycin is represented by a solid line, and Placebo by a dotted line, showing respective decreases in survival over time.*

FDA Label Image

Steady State Graph (Biaxin Tabs Steady Graph)

A line graph comparing mean plasma concentration (mcg/mL) over 24 hours for Biaxin-XL 2 x 500 mg every 24 hours and Biaxin 500 mg every 12 hours. The x-axis represents time after dosing in hours, and the y-axis represents plasma concentration, showing distinct concentration profiles for the two dosing regimens.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.